Thomas P Rice's Net Worth
$6.83 Million
Who is Thomas P Rice?
Thomas P Rice has an estimated net worth of $6.83 Million. This is based on reported shares across multiple companies, which include CHEMED CORP, ANDRX CORP /DE/, and PAR PHARMACEUTICAL COMPANIES, INC..
SEC CIK
Thomas P Rice's CIK is 0001230728
Past Insider Trading and Trends
2011 was Thomas P Rice's most active year for acquiring shares with 3 total transactions. Thomas P Rice's most active month to acquire stocks was the month of April. 2006 was Thomas P Rice's most active year for disposing of shares, totalling 6 transactions. Thomas P Rice's most active month to dispose stocks was the month of January. 2023 saw Thomas P Rice paying a total of $160,432.86 for 294 shares, this is the most they've acquired in one year. In 2006 Thomas P Rice cashed out on 307,368 shares for a total of $3,731,679.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CHEMED CORP (CHE) Snapshot price: $592.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.94% | 284 |
$564.34 | $160,272.56 | 6.03K |
May 20
| |||
Form 4
| +5.39% | 294 |
$545.69 | $160,432.86 | 5.74K |
May 15
| |||
Form 4
| +5.05% | 262 |
$496.25 | $130,017.50 | 5.45K |
May 16
| |||
Form 4
| -13.95% | -841.00 |
$462.47 | -$388,937.27 | 5.19K |
Jun 17
| |||
Form 4
| +4.69% | 270 |
$482.66 | $130,318.20 | 6.03K |
May 17
| |||
Form 4
| +5.09% | 279 |
$466.43 | $130,133.97 | 5.76K |
May 18
| |||
Form 4
| +4.92% | 257 |
$331.69 | $85,244.33 | 5.48K |
May 20
| |||
Form 4
| -27.69% | -2.00K |
$327.67 | -$655,338.48 | 5.22K |
Feb 27
| |||
Form 4
| +3.66% | 255 |
$333.75 | $85,106.25 | 7.22K |
May 21
| |||
Form 4
| +6.38% | 418 |
$203.52 | $85,071.36 | 6.97K |
May 15
| |||
Form 4
| +7.82% | 475 |
$126.53 | $60,101.75 | 6.55K |
May 16
| |||
Form 4
| +8.83% | 493 |
$121.75 | $60,022.75 | 6.08K |
May 18
| |||
Form 4
| +13.85% | 679 |
$88.48 | $60,077.92 | 5.58K |
May 19
| |||
Form 4
| +21.84% | 879 |
$68.26 | $60,000.54 | 4.9K |
May 20
| |||
Form 4
| +36.96% | 1.09K |
$55.29 | $60,044.94 | 4.02K |
May 22
| |||
Form 4
| +41.80% | 866 |
$69.36 | $60,065.76 | 2.94K |
May 16
| |||
Form 4
| +107.20% | 1.07K |
$55.98 | $60,010.56 | 2.07K |
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANDRX CORP /DE/ No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -136.19K |
$25.00 | -$3,404,675.00 |
0
|
Nov 3
| |||
Form 4
| -3.71% | -1.85K |
$23.69 | -$43,921.26 | 48.15K |
Apr 14
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Feb 28
| |||
Form 4
| -24.50% | -4.33K |
$18.45 | -$79,833.15 | 13.33K |
Feb 27
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Apr 14
| |||
Form 4
| -8.62% | -3.53K |
$22.27 | -$78,546.29 | 37.37K |
Feb 27
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PAR PHARMACEUTICAL COMPANIES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||